Atorvastatin Calcium

规格

134523-03-8CAS 号

627-026-0EC 号

calcium bis((3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate)IUPAC 名称

C66H68CaF2N4O10化学式

1155.3 g/mol分子量

ATORVASTATIN CALCIUM; 134523-03-8; Tahor; Atorvastatin calcium anhydrous; CI-981; Liprimar; C0GEJ5QCSO; DTXSID6044303; Atorvastatin calcium (anhydrous); NSC-758617; Calcium (betaR,deltaR)-2-(p-fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoate (1:2); DTXCID4024303; CHEBI:50686; Atorvastatin calcium salt anhydrous; Dengue Kill; RefChem:916455; Atorvastatin, Calcium salt; coffeerazzi minerang dutchcoffee; 658-046-8; 686-242-3; Lipitor; Atorvastatin calcium salt; Atorvastatin hemicalcium salt; Atorvastatin Hemicalcium; calcium (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate; CI 981; Atorvastatin calcium salt trihydrate; Lipitor (TN); 1H-Pyrrole-1-heptanoicacid,2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-,calciumsalt(2:1),(betaR,deltaR)-; Rotacor; Storvas; 363599-71-7; calcium;(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate; CHEMBL393220; Ranbaxy's Storvas; Calcium bis{(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate}; CAS-134523-03-8; UNII-C0GEJ5QCSO; DRG-0321; NCGC00159458-03; YM 548; Atorvastan; Kolevas; Lipibec; Tulip; PD 134298-38A; s2077; Atorvastatin calcium [USAN:USP]; calcium bis((3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate); starbld0032749; Atorvastatin calcium CRS; calcium bis{(3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate}; SCHEMBL3832; Atorvastatin calcium anhydorous; Atorvastatin calcium (Lipitor); GLXC-05131; HMS3884H03; Atorvastatin calcium [EP monograph]; Tox21_111685; Tox21_302373; YM-548; ATORVASTATIN CALCIUM [WHO-DD]; AKOS015896435; Tox21_111685_1; CCG-270648; FA57652; GS-3563; NSC 758617; NCGC00159458-05; NCGC00255845-01; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, calcium salt (2:1), (R-(R*,R*))-; 1H-Pyrrole-1-heptanoic acid, beta,delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, calcium salt (2:1), (R-(R*,R*))-; BA164226; NS00075355; SW219144-1; Atorvastatin calcium salt - Bio-X trade mark; D00887; ATORVASTATIN CALCIUM SALT ANHYDROUS [MI]; Q27888052; (3R,5R)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(pheynylcarbamoyl)pyrrol-1-yl]-3,5-dihydroheptanoic acid, calcium (2:1); 1316891-47-0; 1H-PYRROLE-1-HEPTANOIC ACID, 2-(4-FLUOROPHENYL)-.BETA.,.DELTA.-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-((PHENYLAMINO)CARBONYL)-, CALCIUM SALT (2:1), (R-(R*,R*))-; 1H-PYRROLE-1-HEPTANOIC ACID, 2-(4-FLUOROPHENYL)-.BETA.,.GAMMA.-DIHYDROXY-5- (1-METHYLETHYL)-3-PHENYL-4-((PHENYLAMINO)CARBONYL)-, CALCIUM SALT (2:1), (.BETA.R,.GAMMA.R)-; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-.beta.,delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, calcium salt (2:1),(.beta.R,.delta.R)-; 1H-PYRROLE-1-HEPTANOIC ACID, 2-(4-FLUOROPHENYL)-B,D-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-((PHENYLAMINO)CARBONYL)-, CALCIUM SALT (2:1), (R-(R*,R*))-; 1H-Pyrrole-1-heptanoicacid,2-(4-fluorophenyl)-|A,|A-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-,calciumsalt(2:1),(|AR,|AR)-; CALCIUM (.BETA.R,.DELTA.R)-2-(P-FLUOROPHENYL)-.BETA.,.DELTA.-DIHYDROXY-5-ISOPROPYL-3-PHENYL-4-(PHENYLCARBAMOYL)PYRROLE-1-HEPTANOATE (1:2); Artovastatin calcium; Anhydrous Atorvastatin Calcium同义词